Variant report

Variant	nsv442765
Chromosome Location	chr19:41350994-41380946
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:298)
CpG islands
(count:306)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:298 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41370633-41370945	K562	blood:	n/a	n/a
2	ARID3A	chr19:41378197-41378436	K562	blood:	n/a	n/a
3	ATF1	chr19:41378237-41378485	K562	blood:	n/a	n/a
4	ATF1	chr19:41370536-41370948	K562	blood:	n/a	n/a
5	ATF3	chr19:41378141-41378430	K562	blood:	n/a	n/a
6	ATF3	chr19:41370620-41370877	K562	blood:	n/a	n/a
7	CBX3	chr19:41379769-41380227	K562	blood:	n/a	n/a
8	CBX3	chr19:41370123-41371107	K562	blood:	n/a	n/a
9	CBX3	chr19:41379821-41380148	K562	blood:	n/a	n/a
10	CCNT2	chr19:41370582-41370786	K562	blood:	n/a	n/a
11	CEBPB	chr19:41367289-41367476	A549	lung:	n/a	n/a
12	CEBPB	chr19:41368761-41369068	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr19:41378139-41378466	K562	blood:	n/a	n/a
14	CEBPB	chr19:41362024-41362201	K562	blood:	n/a	n/a
15	CEBPB	chr19:41378202-41378474	K562	blood:	n/a	n/a
16	CEBPB	chr19:41370543-41370910	K562	blood:	n/a	n/a
17	CEBPB	chr19:41373920-41374208	K562	blood:	n/a	n/a
18	CEBPB	chr19:41370209-41371189	K562	blood:	n/a	chr19:41370433-41370441
19	CEBPB	chr19:41368416-41368601	K562	blood:	n/a	n/a
20	CEBPB	chr19:41373834-41374300	A549	lung:	n/a	n/a
21	CEBPB	chr19:41370305-41370801	K562	blood:	n/a	chr19:41370433-41370441
22	CEBPB	chr19:41368480-41368982	A549	lung:	n/a	n/a
23	CEBPB	chr19:41374056-41374100	A549	lung:	n/a	n/a
24	CEBPD	chr19:41370661-41370862	K562	blood:	n/a	n/a
25	CEBPD	chr19:41370295-41371143	K562	blood:	n/a	n/a
26	CTCF	chr19:41368340-41368490	MCF-7	breast:	n/a	n/a
27	CTCF	chr19:41354520-41354670	HCPEpiC	choroid plexus:	n/a	n/a
28	CTCF	chr19:41368540-41368690	AoAF	blood vessel:	n/a	n/a
29	CTCF	chr19:41364100-41364250	HEK293	kidney:	n/a	n/a
30	CTCF	chr19:41354660-41354810	A549	lung:	n/a	chr19:41354699-41354709
31	CTCF	chr19:41354359-41354806	A549	lung:	n/a	chr19:41354699-41354709
32	CTCF	chr19:41364190-41364227	MCF-7	breast:	n/a	n/a
33	CTCF	chr19:41354488-41354703	IMR90	lung:	n/a	n/a
34	CTCF	chr19:41354510-41354631	Medullo	brain:	n/a	n/a
35	CTCF	chr19:41354540-41354690	AG04450	lung:	n/a	n/a
36	CTCF	chr19:41354610-41354641	GM20000	blood:	n/a	n/a
37	CTCF	chr19:41354500-41354650	HL-60	blood:	n/a	n/a
38	CTCF	chr19:41354520-41354670	HPAF	blood vessel:	n/a	n/a
39	CTCF	chr19:41364072-41364366	K562	blood:	n/a	n/a
40	CTCF	chr19:41368380-41368530	NHDF-neo	bronchial:	n/a	n/a
41	CTCF	chr19:41354459-41354759	K562	blood:	n/a	chr19:41354699-41354709
42	CTCF	chr19:41368300-41368450	AG04450	lung:	n/a	n/a
43	CTCF	chr19:41354322-41355358	A549	lung:	n/a	chr19:41355271-41355289 chr19:41354699-41354709
44	CTCF	chr19:41354549-41354665	K562	blood:	n/a	n/a
45	CTCF	chr19:41354520-41354670	HUVEC	blood vessel:	n/a	n/a
46	CTCF	chr19:41364003-41364428	K562	blood:	n/a	n/a
47	CTCF	chr19:41354461-41354702	A549	lung:	n/a	n/a
48	CTCF	chr19:41368380-41368530	HPAF	blood vessel:	n/a	n/a
49	CTCF	chr19:41354521-41354704	Lung_OC	lung:	n/a	n/a
50	CTCF	chr19:41354540-41354690	HPF	lung:	n/a	n/a

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41354682-41354732	AG10803	skin:	n/a
2	chr19:41354682-41354732	AG10803	skin:	n/a
3	chr19:41354142-41354192	ProgFib	skin:	n/a
4	chr19:41354682-41354732	HepG2	liver:	n/a
5	chr19:41354142-41354192	MCF-7	breast:	n/a
6	chr19:41354553-41354603	HUVEC	blood vessel:	n/a
7	chr19:41354682-41354732	SKMC	muscle:	n/a
8	chr19:41354142-41354192	Hela-S3	cervix:	n/a
9	chr19:41354682-41354732	MCF10A-Er-Src	breast:	n/a
10	chr19:41351924-41351974	H1-hESC	embryonic stem cell:	embryo
11	chr19:41354142-41354192	CMK	blood:	n/a
12	chr19:41355973-41356023	H1-hESC	embryonic stem cell:	embryo
13	chr19:41354553-41354603	HCF	heart:	n/a
14	chr19:41354142-41354192	SAEC	small airway:	n/a
15	chr19:41355973-41356023	BE2_C	brain:	n/a
16	chr19:41355973-41356023	ProgFib	skin:	n/a
17	chr19:41354553-41354603	RPTEC	kidney:	n/a
18	chr19:41354553-41354603	T-47D	breast:	n/a
19	chr19:41354682-41354732	BJ	skin:	n/a
20	chr19:41355973-41356023	HCPEpiC	choroid plexus:	n/a
21	chr19:41354682-41354732	T-47D	breast:	n/a
22	chr19:41354682-41354732	LNCaP	prostate:	n/a
23	chr19:41351924-41351974	HEEpiC	esophagus:	n/a
24	chr19:41351924-41351974	SK-N-MC	brain:	n/a
25	chr19:41354142-41354192	SKMC	muscle:	n/a
26	chr19:41354682-41354732	GM06990	blood:	n/a
27	chr19:41354142-41354192	AG10803	skin:	n/a
28	chr19:41354553-41354603	AG09319	gingival:	n/a
29	chr19:41354682-41354732	AG09309	skin:	n/a
30	chr19:41354142-41354192	HCM	heart:	n/a
31	chr19:41354553-41354603	NHDF-neo	bronchial:	n/a
32	chr19:41355973-41356023	MCF10A-Er-Src	breast:	n/a
33	chr19:41354142-41354192	NHDF-neo	bronchial:	n/a
34	chr19:41354553-41354603	HL-60	blood:	n/a
35	chr19:41355973-41356023	PANC-1	pancreas:	n/a
36	chr19:41351924-41351974	NB4	blood:	n/a
37	chr19:41354142-41354192	BJ	skin:	n/a
38	chr19:41354553-41354603	PFSK-1	brain:	n/a
39	chr19:41354682-41354732	HRPEpiC	eye:	n/a
40	chr19:41351924-41351974	ovcar-3	ovarian:	n/a
41	chr19:41354553-41354603	GM12892	blood:	n/a
42	chr19:41351924-41351974	HCF	heart:	n/a
43	chr19:41354682-41354732	Hela-S3	cervix:	n/a
44	chr19:41355973-41356023	HCT-116	colon:	n/a
45	chr19:41351924-41351974	AG09309	skin:	n/a
46	chr19:41354682-41354732	Hepatocyte	liver:	n/a
47	chr19:41355973-41356023	HepG2	liver:	n/a
48	chr19:41354682-41354732	RPTEC	kidney:	n/a
49	chr19:41354142-41354192	HAEpiC	amniotic membrane:	n/a
50	chr19:41354682-41354732	AoSMC	blood vessel:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
2	chr19:41195484..41197379-chr19:41368669..41371255,2	K562	blood:
3	chr16:4474827..4477394-chr19:41351022..41353007,2	MCF-7	breast:
4	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:

No data

Variant related genes	Relation type
CYP2A6	TF binding region
CYP2A6	CpG island
ENSG00000262246	chromatin interactions
ENSG00000105245	chromatin interactions
ENSG00000103423	chromatin interactions

Extended variants
information (count: 1428 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:1428 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs8192729	chr19:41350996-41350997	Weak transcription Enhancers Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs558825772	chr19:41351042-41351043	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs577031756	chr19:41351050-41351051	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs181329462	chr19:41351056-41351057	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs374770548	chr19:41351065-41351066	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs552730967	chr19:41351070-41351071	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs572245201	chr19:41351072-41351073	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs542707063	chr19:41351091-41351092	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs527632948	chr19:41351096-41351097	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs561177628	chr19:41351102-41351103	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs576392235	chr19:41351147-41351148	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs377119322	chr19:41351154-41351155	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs369798042	chr19:41351166-41351167	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs386809288	chr19:41351169-41351170	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs60286635	chr19:41351170-41351171	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs532833480	chr19:41351178-41351179	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs202136237	chr19:41351189-41351190	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs28399455	chr19:41351190-41351191	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs201588233	chr19:41351195-41351196	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs142724678	chr19:41351198-41351199	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs72547582	chr19:41351200-41351201	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs369136003	chr19:41351207-41351208	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs150586234	chr19:41351211-41351212	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs372636737	chr19:41351216-41351217	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs185304177	chr19:41351226-41351227	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs114558780	chr19:41351227-41351228	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs59992959	chr19:41351244-41351245	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs145036049	chr19:41351245-41351246	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs142447929	chr19:41351251-41351252	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs147883801	chr19:41351261-41351262	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs28399454	chr19:41351267-41351268	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs375925239	chr19:41351289-41351290	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs143841823	chr19:41351305-41351306	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs148166815	chr19:41351309-41351310	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs200267449	chr19:41351321-41351322	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs141074424	chr19:41351324-41351325	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs150247689	chr19:41351344-41351345	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs374200109	chr19:41351354-41351355	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs138932530	chr19:41351355-41351356	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs61605570	chr19:41351363-41351364	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs146206761	chr19:41351368-41351369	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs137904044	chr19:41351370-41351371	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs535231886	chr19:41351376-41351377	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs546089312	chr19:41351382-41351383	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs188167379	chr19:41351393-41351394	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs28399453	chr19:41351400-41351401	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs148057229	chr19:41351429-41351430	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs528694759	chr19:41351436-41351437	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs577654198	chr19:41351448-41351449	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs2388874	chr19:41351456-41351457	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:182 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41349600-41351200	Enhancers	Primary T helper naive cells from peripheral blood	blood
2	chr19:41349600-41351200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
3	chr19:41349800-41351200	Weak transcription	Right Ventricle	heart
4	chr19:41349800-41353800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr19:41350000-41351000	Enhancers	Primary T killer memory cells from peripheral blood	blood
6	chr19:41350000-41351000	Weak transcription	Pancreas	Pancrea
7	chr19:41350000-41351400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
8	chr19:41350000-41352600	Weak transcription	Lung	lung
9	chr19:41350000-41353000	Strong transcription	Liver	Liver
10	chr19:41350200-41351000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr19:41350200-41351200	Enhancers	Primary T cells fromperipheralblood	blood
12	chr19:41350400-41351200	Enhancers	Primary neutrophils fromperipheralblood	blood
13	chr19:41350600-41354400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
14	chr19:41350800-41354400	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
15	chr19:41351000-41354600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
16	chr19:41351200-41354400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
17	chr19:41351200-41354400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
18	chr19:41351400-41351600	Enhancers	Esophagus	oesophagus
19	chr19:41351400-41351600	Enhancers	Right Ventricle	heart
20	chr19:41351400-41354200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
21	chr19:41352800-41353000	Enhancers	Lung	lung
22	chr19:41352800-41354400	Weak transcription	Pancreas	Pancrea
23	chr19:41353000-41353600	Weak transcription	Lung	lung
24	chr19:41353000-41354000	Weak transcription	Liver	Liver
25	chr19:41353600-41354800	Enhancers	Lung	lung
26	chr19:41353800-41354000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
27	chr19:41353800-41354200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr19:41353800-41354200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr19:41353800-41354800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
30	chr19:41354000-41354200	Enhancers	Liver	Liver
31	chr19:41354000-41354800	Enhancers	Spleen	Spleen
32	chr19:41354200-41354400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
33	chr19:41354200-41354400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
34	chr19:41354200-41354400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
35	chr19:41354200-41354400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
36	chr19:41354200-41354400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
37	chr19:41354200-41354400	Enhancers	Ovary	ovary
38	chr19:41354200-41354600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
39	chr19:41354200-41354600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr19:41354200-41354600	Flanking Active TSS	Liver	Liver
41	chr19:41354200-41354800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
42	chr19:41354200-41354800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
43	chr19:41354200-41354800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
44	chr19:41354200-41354800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
45	chr19:41354200-41355000	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
46	chr19:41354200-41355000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
47	chr19:41354400-41354600	Flanking Bivalent TSS/Enh	Primary T helper cells PMA-I stimulated	--
48	chr19:41354400-41354600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
49	chr19:41354400-41354600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
50	chr19:41354400-41354600	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links